Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,290,573 papers from all fields of science
Search
Sign In
Create Free Account
OPC 14117
Known as:
1-Piperazineacetamide, N-(2,3-dihydro-7-hydroxy-2,2,4,6-tetramethyl-1H-inden-1-yl)-4-(3-methoxyphenyl)-
, OPC-14117
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Indans
Piperazines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Effects of antioxidant, OPC-14117, on secondary cellular damage and behavioral deficits following cortical contusion in the rat
Naoki Aoyama
,
Y. Katayama
,
+5 authors
Yasuhumi Uwahodo
Brain Research
2002
Corpus ID: 44456654
2000
2000
NMDA and non-NMDA receptor-stimulated IkappaB-alpha degradation: differential effects of the caspase-3 inhibitor DEVD.CHO, ethanol and free radical scavenger OPC-14117.
M. Nakai
,
Z. Qin
,
Y. Wang
,
T. Chase
Brain Research
2000
Corpus ID: 46313838
The excitotoxic response of striatal neurons to NMDA and non-NMDA receptor agonists involves the nuclear translocation of…
Expand
1998
1998
Antioxidant, OPC-14117, attenuates edema formation, and subsequent tissue damage following cortical contusion in rats.
Tatsuro Mori
,
T. Kawamata
,
+4 authors
Y. Uwahodo
Acta neurochirurgica. Supplement
1998
Corpus ID: 28973259
Oxygen free radicals contribute to various kinds of tissue injury processes within the central nervous system. It has been…
Expand
1998
1998
Safety and tolerability of the free-radical scavenger OPC-14117 in Huntington's disease. The Huntington Study Group.
Neurology
1998
Corpus ID: 24963785
Oxidative damage due to free-radical generation in the setting of underlying defects of neuronal energy metabolism has been…
Expand
1998
1998
Chronic Exposure to MPTP as a Primate Model of Progressive Parkinsonism: A Pilot Study with a Free Radical Scavenger
P. Blanchet
,
S. Konitsiotis
,
K. Hyland
,
L. Arnold
,
K. Pettigrew
,
T. Chase
Experimental Neurology
1998
Corpus ID: 37442583
The development of a validated primate model of progressive parkinsonism is a critical step in the evaluation of drugs that might…
Expand
1997
1997
Protective effect of a novel free radical scavenger, OPC‐14117, on wobbler mouse motor neuron disease
Koji Abe
,
S. Morita
,
T. Kikuchi
,
Y. Itoyama
Journal of Neuroscience Research
1997
Corpus ID: 20752343
A possible protective effect of a novel free radical scavenger, OPC‐14117, on the progressive motor neuron death in wobbler mice…
Expand
1997
1997
Antioxidant, OPC-14117, attenuates edema formation and behavioral deficits following cortical contusion in rats.
T. Kawamata
,
Y. Katayama
,
+4 authors
Y. Uwahodo
Acta neurochirurgica. Supplement
1997
Corpus ID: 23176352
Oxygen free radicals may contribute to tissue injury processes in the central nervous system following ischemia or trauma. Recent…
Expand
1997
1997
Safety and tolerability of the antioxidant OPC-14117 in HIV-associated cognitive impairment. The Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders.
Neurology
1997
Corpus ID: 38277374
Cognitive impairment is a common and disabling complication of advanced HIV infection. Antiretroviral agents are the only proven…
Expand
1991
1991
Evaluation of superoxide scavenging activity of OPC-14117 by electron spin resonance technique.
J. Jinno
,
H. Mori
,
Y. Oshiro
,
T. Kikuchi
,
H. Sakurai
Free Radical Research Communications
1991
Corpus ID: 22637895
OPC-14117 is a potent drug which has both brain function activating effect and protective effect against cerebral ischemia…
Expand
1991
1991
Novel cerebroprotective agents with central nervous system stimulating activity. 2. Synthesis and pharmacology of the 1-(acylamino)-7-hydroxyindan derivatives.
Y. Oshiro
,
Y. Sakurai
,
T. Tanaka
,
T. Kikuchi
,
T. Hirose
,
K. Tottori
Journal of Medicinal Chemistry
1991
Corpus ID: 19789260
In a continuous search for a novel cerebroprotective drug with a central nervous system (CNS) stimulating activity, a series of 1…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE